Archived Funding Opportunities
Previous/Archived Targeted Program Announcements (PAs):
- Development of a Device to Objectively Measure Pain [RFA-DA-18-012][RFA-DA-18-013]
- PHS 2016-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications [PA-16-302 (R43/R44)]
- PHS 2015-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications [PA-15-270 (R41/R42)]
- PHS 2015-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications [PA-15-269 (R43/R44)]
- Platform Delivery Technologies for Nucleic Acid Therapeutics [PA-14-308 (R41/R42)][PA-14-307 (R43/R44)]
- Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science [PA-14-154 (R43/R44)][PA-14-157 (R41/R42)]
Previous/Archived Targeted Requests for Applications (RFAs):
- Digital Technologies to Address the Social Determinants of Health in Context of Substance Use Disorders [RFA-DA-21-031][RFA-DA-21-032]
- Novel Approaches to Decrease Stigma of Substance Use Disorders in Order to Facilitate Prevention, Treatment, and Supporting During Recovery [RFA-DA-21-015][RFA-DA-21-016]
- Rapid Assessment of Drug Abuse: Smart City Tools [RFA-DA-20-020][RFA-DA-20-021]
- Digital Health Technologies to Address the Social Determinants of Health in Context of Substance Use Disorders (SUD) [RFA-DA-20-017][RFA-DA-20-018]
- Blockchain Technology to Improve SUD Care [RFA-DA-20-011][RFA-DA-20-012]
- Virtual Reality Tools to Enhance Evidence Based Treatment of Substance Use Disorders [RFA-DA-19-032][RFA-DA-19-033]
- Mobile Technologies Extending Reach of Primary Care for Substance-Use-Disorders [RFA-DA-19-021][RFA-DA-19-022]
- Analytical Tools and Approaches for (Multidimensional) Scholarly Research Assessment and Decision Support in the Biomedical Enterprise [RFA-DA-19-030][RFA-DA-19-031]
- Development of a Device to Objectively Measure Pain [RFA-DA-18-012][RFA-DA-18-013]
- Nasal Delivery of CNS Therapeutics [RFA-DA-18-006 (R43/R44)][RFA-DA-18-007 (R41/R42)]
- Wearable to Track Recovery and Relapse Factors for People w/ Addiction [RFA-DA-18-010 (R43/R44)]
- Extracellular Vesicle Tools, Technologies, and Products for Neuroscience Research [RFA-DA-17-008 (R41/R42)][RFA-DA-17-009 (R43/R44)]
- Improved Technologies and Ligands for Non-invasive Brain Imaging [RFA-DA-17-010 (R41/R42)][RFA-DA-17-011 (R43/R44)]
- Laboratory and Diagnostic Tools to Advance Microbiome-Brain Research [RFA-DA-17-016 (R41)][RFA-DA-17-017 (R43/R44)]
- Tools and Services for Designing Methodologically Rigorous Animal Studies [RFA-DA-16-003 (R43/R44)][RFA-DA-16-002 (R41/R42)]
- Tools for Monitoring and Manipulating Modified RNAs in the Nervous System [RFA-DA-15-001 (R43/R44)][RFA-DA-15-002 (R41/R42)][RFA-DA-16-005 (R43/R44)][RFA-DA-16-006 (R41/R42)]
- Abuse-Resistant and Abuse-Deterrent Formulations and Devices to Avoid the Abuse, Misuse and Diversion of Prescription Opioids by Patients (SBIR) [RFA-DA-14-013 (R43/R44)]
- Pharmacological Development of Treatment Agents and Formulations for Tobacco Dependence [(STTR [R41]) RFA-DA-11-004]
- Small Business Alzheimer's Disease Research [RFA-OD-12-003 (SBIR[R43/R44])][RFA-OD-12-004 (STTR [R41/R42])]
- Recovery Act Limited Competition: Small Business Catalyst Awards for Accelerating Innovative Research [RFA-OD-09-009 (R43)]
) means that you are leaving the NIH SBIR/STTR website. Such external links provide additional information that is consistent with the intended purpose of this site. The NIH SBIR/STTR program cannot attest to the accuracy of a non NIH SBIR/STTR webpages.